DexCom, Inc.(DXCM)Earnings, Financials & Key Ratios

DXCM•NASDAQ

$60.36

$23.29B mkt cap·28.9× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryDiabetes care and insulin delivery

AboutDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.Show more

Revenue$4.66B+15.6%
EBITDA$1.16B+42.3%
Net Income$836M+45.1%
EPS (Diluted)2.09+47.2%
Gross Margin60.01%-0.7%
EBITDA Margin24.96%+23.1%
Operating Margin19.56%+31.5%
Net Margin17.94%+25.6%
ROE34.5%+24.9%
ROIC18.73%+70.2%
Debt/Equity0.51-58.9%
Interest Coverage49.83+30.0%

Analysis→Technical→

DXCM Key Insights

DexCom, Inc. (DXCM) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 29.3%
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 23.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 19.3%
✓Healthy 5Y average net margin of 13.6%

✗Weaknesses

✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

DXCM Price & Volume

DexCom, Inc. (DXCM) stock price & volume — 10-year historical chart

Loading chart...

DXCM Growth Metrics

DexCom, Inc. (DXCM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years27.77%

5 Years19.33%

3 Years17.01%

TTM16.15%

Profit CAGR

10 Years-

5 Years11.12%

3 Years34.83%

TTM73.84%

EPS CAGR

10 Years-

5 Years10.48%

3 Years37.73%

TTM74.63%

Return on Capital

10 Years4%

5 Years13.87%

3 Years17.51%

Last Year23.53%

DXCM Recent Earnings

DexCom, Inc. (DXCM) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 11/12 qtrs (92%)

Q2 2026Latest

Apr 30, 2026

EPS

$0.56

Est $0.47

+19.1%

Revenue

$1.2B

Est $1.2B

+1.5%

Q1 2026

Feb 12, 2026

EPS

$0.68

Est $0.65

+4.6%

Revenue

$1.3B

Est $1.2B

+0.9%

Q4 2025

Oct 30, 2025

EPS

$0.61

Est $0.58

+5.9%

Revenue

$1.2B

Est $1.2B

+2.2%

Q3 2025

Jul 30, 2025

EPS

$0.48

Est $0.44

+8.2%

Revenue

$1.2B

Est $1.1B

+2.9%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 30, 2026	$0.56vs $0.47+19.1%	$1.2Bvs $1.2B+1.5%
Q1 2026	Feb 12, 2026	$0.68vs $0.65+4.6%	$1.3Bvs $1.2B+0.9%
Q4 2025	Oct 30, 2025	$0.61vs $0.58+5.9%	$1.2Bvs $1.2B+2.2%
Q3 2025	Jul 30, 2025	$0.48vs $0.44+8.2%	$1.2Bvs $1.1B+2.9%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
ABTAbbott LaboratoriesDirect Competitor	149.97B	86.25	11.29	4.59%	31.88%	27.26%	0.32
PODDInsulet CorporationDirect Competitor	10.61B	151.17	43.44	30.73%	10.44%	21.38%	0.69
TNDMTandem Diabetes Care, Inc.Direct Competitor	1.24B	18.03	-5.93	7.93%	-20.17%	-141.98%	2.86
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
INVAInnoviva, Inc.Direct Competitor	1.91B	22.52	6.82	18.52%	118.91%	46.47%	0.23
MDTMedtronic plcProduct Competitor	99.48B	77.60	21.50	3.62%	13%	9.45%	0.59
PHGKoninklijke Philips N.V.Product Competitor	25.9B	27.23	24.95	-1.04%	5.02%	8.19%	0.74
ITGRInteger Holdings CorporationProduct Competitor	2.97B	86.29	29.86	7.57%	7.67%	8.23%	0.80

Compare DXCM vs Peers

DexCom, Inc. (DXCM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ABT

Most directly comparable listed peer for DXCM.

Scale Benchmark

vs GOOG

Larger-name benchmark to compare DXCM against a more recognizable public peer.

Peer Set

Compare Top 5

vs ABT, PODD, TNDM, NVCR

DXCM Income Statement

DexCom, Inc. (DXCM) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	718.5M	1.03B	1.48B	1.93B	2.45B	2.91B	3.62B	4.03B	4.66B	4.82B
Revenue Growth %	25.33%	43.58%	43.08%	30.54%	27.08%	18.84%	24.49%	11.34%	15.6%	16.15%
Cost of Goods Sold	226.4M	367.7M	544.5M	646.6M	768M	1.03B	1.33B	1.59B	1.86B	1.84B
COGS % of Revenue	31.51%	35.64%	36.89%	33.56%	31.37%	35.28%	36.81%	39.54%	39.99%	-
Gross Profit	492.1M▲ 0%	663.9M▲ 34.9%	931.5M▲ 40.3%	1.28B▲ 37.4%	1.68B▲ 31.3%	1.88B▲ 12.1%	2.29B▲ 21.5%	2.44B▲ 6.5%	2.8B▲ 14.7%	2.98B▲ 0%
Gross Margin %	68.49%	64.36%	63.11%	66.44%	68.63%	64.72%	63.19%	60.46%	60.01%	61.84%
Gross Profit Growth %	30.05%	34.91%	40.31%	37.42%	31.28%	12.06%	21.55%	6.52%	14.74%	-
Operating Expenses	534.6M	850.2M	789.2M	980.6M	1.41B	1.49B	1.69B	1.84B	1.89B	1.95B
OpEx % of Revenue	74.41%	82.42%	53.47%	50.9%	57.78%	51.27%	46.69%	45.58%	40.45%	-
Selling, General & Admin	349.2M	432.8M	515.7M	620.7M	810.5M	1.01B	1.19B	1.29B	1.29B	1.33B
SG&A % of Revenue	48.6%	41.95%	34.94%	32.22%	33.1%	34.63%	32.73%	31.88%	27.69%	-
Research & Development	185.4M	417.4M	273.5M	359.9M	604.2M	484.2M	505.8M	552.4M	594.9M	599.2M
R&D % of Revenue	25.8%	40.46%	18.53%	18.68%	24.68%	16.64%	13.96%	13.7%	12.76%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	1000K
Operating Income	-42.5M▲ 0%	-186.3M▼ 338.4%	142.3M▲ 176.4%	299.5M▲ 110.5%	265.8M▼ 11.3%	391.2M▲ 47.2%	597.7M▲ 52.8%	600M▲ 0.4%	911.8M▲ 52.0%	1.03B▲ 0%
Operating Margin %	-5.92%	-18.06%	9.64%	15.54%	10.86%	13.44%	16.5%	14.88%	19.56%	21.45%
Operating Income Growth %	33.49%	-338.35%	176.38%	110.47%	-11.25%	47.18%	52.79%	0.38%	51.97%	-
EBITDA	-26.4M	-157.2M	191M	366.6M	367.7M	547.1M	783.7M	817.7M	1.16B	1.23B
EBITDA Margin %	-3.67%	-15.24%	12.94%	19.03%	15.02%	18.8%	21.64%	20.28%	24.96%	25.43%
EBITDA Growth %	46.01%	-495.45%	221.5%	91.94%	0.3%	48.79%	43.25%	4.34%	42.3%	42.83%
D&A (Non-Cash Add-back)	16.1M	29.1M	48.7M	67.1M	101.9M	155.9M	186M	217.7M	251.8M	191.8M
EBIT	-35.8M	-103.8M	164.5M	309.7M	275.6M	409.4M	730.7M	728M	911.8M	778.1M
Net Interest Income	-6.1M	-20.3M	-33.9M	-68.6M	-17.1M	5.2M	114.7M	115.2M	94.4M	70.6M
Interest Income	6.7M	2.4M	26.4M	16.1M	1.7M	23.8M	135M	134.2M	112.7M	84.2M
Interest Expense	12.8M	22.7M	60.3M	84.7M	18.8M	18.6M	20.3M	19M	18.3M	13.6M
Other Income/Expense	-6.1M	59.8M	-38.1M	-74.5M	-9M	-400K	112.7M	109M	176.6M	170.2M
Pretax Income	-48.6M▲ 0%	-126.5M▼ 160.3%	104.2M▲ 182.4%	225M▲ 115.9%	256.8M▲ 14.1%	390.8M▲ 52.2%	710.4M▲ 81.8%	709M▼ 0.2%	1.09B▲ 53.5%	1.2B▲ 0%
Pretax Margin %	-6.76%	-12.26%	7.06%	11.68%	10.49%	13.43%	19.61%	17.58%	23.35%	24.98%
Income Tax	1.6M	600K	3.1M	-268.6M	39.9M	49.6M	168.9M	132.8M	252.1M	273.2M
Effective Tax Rate %	-3.29%	-0.47%	2.98%	-119.38%	15.54%	12.69%	23.78%	18.73%	23.16%	22.7%
Net Income	-50.2M▲ 0%	-127.1M▼ 153.2%	101.1M▲ 179.5%	493.6M▲ 388.2%	216.9M▼ 56.1%	341.2M▲ 57.3%	541.5M▲ 58.7%	576.2M▲ 6.4%	836.3M▲ 45.1%	930.4M▲ 0%
Net Margin %	-6.99%	-12.32%	6.85%	25.62%	8.86%	11.73%	14.95%	14.29%	17.94%	19.31%
Net Income Growth %	23.48%	-153.19%	179.54%	388.23%	-56.06%	57.31%	58.7%	6.41%	45.14%	73.84%
Net Income (Continuing)	-50.2M	-127.1M	101.1M	493.6M	216.9M	341.2M	541.5M	576.2M	836.3M	930.4M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.15▲ 0%	-0.36▼ 140.0%	0.27▲ 175.0%	1.27▲ 370.4%	0.51▼ 59.8%	0.80▲ 56.9%	1.30▲ 62.5%	1.42▲ 9.2%	2.09▲ 47.2%	2.36▲ 0%
EPS Growth %	25%	-140%	175%	370.37%	-59.84%	56.86%	62.5%	9.23%	47.18%	74.63%
EPS (Basic)	-0.15	-0.36	0.28	1.31	0.56	0.88	1.44	1.46	2.14	-
Diluted Shares Outstanding	345.2M	352.8M	369.2M	390M	428.8M	427.5M	425.5M	412.7M	405.5M	393.6M
Basic Shares Outstanding	345.2M	352.8M	364.4M	377.6M	386.9M	389.4M	386M	404.63M	390.2M	385.1M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

DXCM Balance Sheet

DexCom, Inc. (DXCM) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	744.7M	1.7B	1.97B	3.42B	3.68B	3.67B	4.43B	4.3B	4.03B	4.33B
Cash & Short-Term Investments	548.6M	1.39B	1.53B	2.71B	2.73B	2.46B	2.72B	2.58B	2B	2.42B
Cash Only	441.5M	1.14B	446.2M	817.6M	1.05B	642.3M	566.3M	606.1M	917.7M	1.12B
Short-Term Investments	107.1M	248.6M	1.09B	1.89B	1.68B	1.81B	2.16B	1.97B	1.08B	1.3B
Accounts Receivable	134.3M	226.7M	286.3M	428.5M	516.6M	752.2M	987.5M	1.03B	1.29B	1.09B
Days Sales Outstanding	68.22	80.21	70.8	81.18	77.01	94.35	99.51	93.54	100.99	93.28
Inventory	45.2M	70.7M	119.8M	234.7M	357.3M	306.7M	559.6M	542.6M	629.1M	693.6M
Days Inventory Outstanding	72.87	70.18	80.31	132.49	169.81	109.03	153.18	124.18	123.17	123.94
Other Current Assets	0	0	0	0	27.4M	37M	64.5M	58.3M	49.2M	134.3M
Total Non-Current Assets	159.4M	216.5M	425.6M	865.7M	1.25B	1.72B	1.84B	2.18B	2.31B	2.3B
Property, Plant & Equipment	145.6M	183.1M	392.8M	608.6M	889.9M	1.14B	1.18B	1.4B	1.64B	1.63B
Fixed Asset Turnover	4.93x	5.63x	3.76x	3.17x	2.75x	2.56x	3.06x	2.88x	2.85x	3.05x
Goodwill	12.1M	18.7M	18.6M	19.3M	26.5M	25.7M	25.2M	22.8M	24.2M	24.2M
Intangible Assets	0	0	0	21.4M	31.5M	173.3M	134.5M	103.4M	70.8M	62.6M
Long-Term Investments	0	0	0	0	0	19M	38.5M	119.3M	218M	550.7M
Other Non-Current Assets	1.7M	14.7M	14.2M	0	10.5M	28.1M	36.5M	53.7M	60.7M	465.9M
Total Assets	904.1M▲ 0%	1.92B▲ 111.9%	2.4B▲ 25.0%	4.29B▲ 79.1%	4.93B▲ 15.0%	5.39B▲ 9.3%	6.26B▲ 16.2%	6.48B▲ 3.5%	6.34B▼ 2.2%	6.63B▲ 0%
Asset Turnover	0.79x	0.54x	0.62x	0.45x	0.50x	0.54x	0.58x	0.62x	0.74x	0.69x
Asset Growth %	124.45%	111.92%	25%	79.14%	14.98%	9.29%	16.19%	3.51%	-2.23%	21.82%
Total Current Liabilities	138.9M	222.4M	360.2M	614.1M	720.8M	1.84B	1.56B	2.93B	2.14B	2.22B
Accounts Payable	46.7M	75.5M	102.3M	163.3M	189.4M	237.9M	276.4M	345.3M	344.3M	0
Days Payables Outstanding	75.29	74.95	68.58	92.18	90.01	84.58	75.66	79.03	67.41	62.92
Short-Term Debt	0	0	0	0	0	772.6M	0	1.2B	0	20.5M
Deferred Revenue (Current)	3.2M	2.9M	1.7M	2.2M	2.1M	10.1M	18.4M	8M	7.7M	16.7M
Other Current Liabilities	0	0	0	26.6M	48.4M	47.7M	46.4M	56.1M	54.6M	2.2B
Current Ratio	5.36x	7.64x	5.47x	5.58x	5.11x	1.99x	2.84x	1.47x	1.88x	1.88x
Quick Ratio	5.04x	7.32x	5.13x	5.19x	4.62x	1.83x	2.48x	1.28x	1.59x	1.59x
Cash Conversion Cycle	65.81	75.45	82.53	121.48	156.81	118.81	177.03	138.7	156.75	154.3
Total Non-Current Liabilities	345.8M	1.03B	1.15B	1.85B	2.17B	1.42B	2.64B	1.45B	1.45B	1.45B
Long-Term Debt	327.6M	1.01B	1.06B	1.67B	1.98B	1.2B	2.43B	1.24B	1.24B	1.31B
Capital Lease Obligations	6.7M	7.3M	86.8M	155.8M	155.6M	154.2M	138.7M	123.5M	127.2M	343.3M
Deferred Tax Liabilities	0	0	0	0	5.9M	4.9M	0	0	0	0
Other Non-Current Liabilities	11.5M	12.7M	5.7M	26.9M	11M	44.8M	59.6M	79.9M	83.3M	413.3M
Total Liabilities	484.7M	1.25B	1.51B	2.46B	2.89B	3.26B	4.2B	4.38B	3.59B	3.68B
Total Debt	334.3M	1.02B	1.16B	1.84B	2.16B	2.15B	2.59B	2.59B	1.39B	1.33B
Net Debt	-107.2M	-119.4M	713.9M	1.02B	1.11B	1.5B	2.03B	1.98B	472M	213.1M
Debt / Equity	0.80x	1.53x	1.31x	1.01x	1.06x	1.01x	1.25x	1.23x	0.51x	0.51x
Debt / EBITDA	-	-	6.07x	5.02x	5.87x	3.92x	3.31x	3.16x	1.19x	1.09x
Net Debt / EBITDA	-	-	3.74x	2.79x	3.01x	2.75x	2.59x	2.42x	0.41x	0.41x
Interest Coverage	-2.80x	-4.57x	2.73x	3.66x	14.66x	22.01x	36.00x	38.32x	49.83x	57.21x
Total Equity	419.4M▲ 0%	663.3M▲ 58.2%	882.6M▲ 33.1%	1.83B▲ 106.9%	2.04B▲ 11.8%	2.13B▲ 4.4%	2.07B▼ 3.0%	2.1B▲ 1.6%	2.75B▲ 30.6%	2.96B▲ 0%
Equity Growth %	47.78%	58.15%	33.06%	106.95%	11.8%	4.39%	-2.96%	1.64%	30.6%	104.51%
Book Value per Share	1.21	1.88	2.39	4.68	4.76	4.99	4.86	5.09	6.77	7.51
Total Shareholders' Equity	419.4M	663.3M	882.6M	1.83B	2.04B	2.13B	2.07B	2.1B	2.75B	2.96B
Common Stock	100K	100K	100K	100K	400K	400K	400K	400K	400K	400K
Retained Earnings	-671.8M	-798.9M	-695.7M	-202.1M	138.7M	479.9M	1.02B	1.6B	2.43B	2.63B
Treasury Stock	0	-100M	-100M	-100M	-206.2M	-595M	-2.45B	-1.58B	-2.08B	0
Accumulated OCI	-2.6M	1.5M	2.3M	3.2M	500K	-11.6M	-16.7M	-8M	115M	106.2M
Minority Interest	0	0	0	0	0	0	0	0	0	0

DXCM Cash Flow Statement

DexCom, Inc. (DXCM) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	92M	123.2M	314.5M	475.6M	442.5M	669.5M	748.5M	989.5M	1.44B	1.44B
Operating CF Margin %	12.8%	11.94%	21.31%	24.68%	18.07%	23.01%	20.66%	24.54%	30.9%	-
Operating CF Growth %	63.7%	33.91%	155.28%	51.22%	-6.96%	51.3%	11.8%	32.2%	45.6%	422.73%
Net Income	-50.2M	-127.1M	101.1M	493.6M	154.7M	341.2M	541.5M	576.2M	836.3M	930.4M
Depreciation & Amortization	16.1M	29.1M	48.7M	67.1M	102M	155.9M	186M	217.7M	251.8M	258.9M
Stock-Based Compensation	106.2M	101.9M	102.7M	119.4M	113.4M	126.5M	150.8M	170.4M	159.6M	168.7M
Deferred Taxes	0	-80.1M	4.2M	-277.3M	-4.9M	-21.6M	-55M	-43.8M	182.2M	188.3M
Other Non-Cash Items	17.3M	240.3M	51.7M	93.6M	209.3M	39.8M	-78M	-39.8M	-92.6M	-14.3M
Working Capital Changes	2.6M	-40.9M	6.1M	-20.8M	-132M	27.7M	3.2M	108.8M	103.4M	250.5M
Change in Receivables	-31.8M	-93.2M	-60M	-142.3M	-75.5M	-199.9M	-260.1M	-35M	-201.9M	-177.6M
Change in Inventory	400K	-25.5M	-49.1M	-114.5M	-112.2M	49.3M	-252.6M	12.4M	-63.7M	-4.7M
Change in Payables	21.1M	56.2M	109M	194.5M	58M	295.1M	466.5M	211.7M	347M	366.7M
Cash from Investing	-144.4M	-139.8M	-1.02B	-1.02B	-216.1M	-521.5M	-507.2M	-207.5M	536M	137.3M
Capital Expenditures	-66M	-67.1M	-180M	-199M	-389.2M	-364.8M	-236.6M	-358.8M	-363.5M	-353.1M
CapEx % of Revenue	9.19%	6.5%	12.2%	10.33%	15.9%	12.54%	6.53%	8.9%	7.8%	-
Acquisitions	0	-11.3M	835.2M	0	-30.2M	-3.9M	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-78.4M	-61.4M	-835.2M	-11.3M	10.1M	-14.3M	-17.6M	-15.5M	600K	-400K
Cash from Financing	399.1M	710.4M	10.7M	912.1M	10.4M	-552.5M	-318.6M	-734.8M	-1.69B	-1.72B
Debt Issued (Net)	389M	836.6M	0	906.2M	0	0	443.3M	0	-1.21B	0
Equity Issued (Net)	10.1M	-89.2M	11.9M	15.3M	20.3M	-535.2M	-662.1M	-721.8M	-471.9M	-509.2M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	-100M	0	0	0	-557.7M	-688.7M	-750M	-500M	-535.8M
Other Financing	0	-37M	-1.2M	-9.4M	-9.9M	-17.3M	-99.8M	-13M	-7M	-1.21B
Net Change in Cash	347M▲ 0%	695.6M▲ 100.5%	-690.7M▼ 199.3%	371.8M▲ 153.8%	235.4M▼ 36.7%	-410.3M▼ 274.3%	-75.8M▲ 81.5%	39.8M▲ 152.5%	311.8M▲ 683.4%	212.3M▲ 0%
Free Cash Flow	26M▲ 0%	56.1M▲ 115.8%	134.5M▲ 139.8%	276.6M▲ 105.7%	53.3M▼ 80.7%	304.7M▲ 471.7%	511.9M▲ 68.0%	630.7M▲ 23.2%	1.08B▲ 70.8%	1.43B▲ 0%
FCF Margin %	3.62%	5.44%	9.11%	14.36%	2.18%	10.47%	14.13%	15.64%	23.11%	29.67%
FCF Growth %	5100%	115.77%	139.75%	105.65%	-80.73%	471.67%	68%	23.21%	70.79%	148.5%
FCF per Share	0.08	0.16	0.36	0.71	0.12	0.71	1.20	1.53	2.66	2.66
FCF Conversion (FCF/Net Income)	-1.83x	-0.97x	3.11x	0.96x	2.04x	1.96x	1.38x	1.72x	1.72x	1.54x
Interest Paid	2.4M	3.6M	10.4M	10.6M	11.6M	12.2M	12.4M	11.4M	11.4M	0
Taxes Paid	1.4M	2.3M	4.8M	3.6M	16.8M	114.2M	212.3M	198M	94.4M	0

DXCM Key Ratios

DexCom, Inc. (DXCM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-14.28%	-23.48%	13.08%	36.44%	11.21%	16.35%	25.78%	27.63%	34.5%	33.83%
Return on Invested Capital (ROIC)	-12.54%	-32.64%	9.97%	10.11%	6.65%	8.65%	11.6%	11%	18.73%	18.73%
Gross Margin	68.49%	64.36%	63.11%	66.44%	68.63%	64.72%	63.19%	60.46%	60.01%	61.84%
Net Margin	-6.99%	-12.32%	6.85%	25.62%	8.86%	11.73%	14.95%	14.29%	17.94%	19.31%
Debt / Equity	0.80x	1.53x	1.31x	1.01x	1.06x	1.01x	1.25x	1.23x	0.51x	0.51x
Interest Coverage	-2.80x	-4.57x	2.73x	3.66x	14.66x	22.01x	36.00x	38.32x	49.83x	57.21x
FCF Conversion	-1.83x	-0.97x	3.11x	0.96x	2.04x	1.96x	1.38x	1.72x	1.72x	1.54x
Revenue Growth	25.33%	43.58%	43.08%	30.54%	27.08%	18.84%	24.49%	11.34%	15.6%	16.15%

DXCM SEC Filings & Documents

DexCom, Inc. (DXCM) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Mar 2, 2026·SEC

Material company update

Feb 26, 2026·SEC

10-K Annual Reports

FY 2026

Feb 12, 2026·SEC

FY 2024

Feb 8, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 30, 2025·SEC

DXCM Frequently Asked Questions

DexCom, Inc. (DXCM) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

DexCom, Inc. (DXCM) reported $4.82B in revenue for fiscal year 2025.

DexCom, Inc. (DXCM) grew revenue by 15.6% over the past year. This is strong growth.

Yes, DexCom, Inc. (DXCM) is profitable, generating $930.4M in net income for fiscal year 2025 (17.9% net margin).

Dividend & Returns

DexCom, Inc. (DXCM) has a return on equity (ROE) of 34.5%. This is excellent, indicating efficient use of shareholder capital.

DexCom, Inc. (DXCM) generated $1.43B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More DXCM

DexCom, Inc. (DXCM) financial analysis — history, returns, DCA and operating performance tools

Full DXCM Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

DexCom, Inc.(DXCM)Earnings, Financials & Key Ratios

DXCM Key Insights

✓Strengths

✗Weaknesses

DXCM Price & Volume

DXCM Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

DXCM Recent Earnings

DXCM Peer Comparison

Compare DXCM vs Peers

vs ABT

vs GOOG

Compare Top 5

DXCM Income Statement

DXCM Balance Sheet

DXCM Cash Flow Statement

DXCM Key Ratios

DXCM SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

DXCM Frequently Asked Questions

Explore More DXCM

Full DXCM Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation